Mabion Signs Expansion Of Production Deal With Novavax
Aug 2 (Reuters) - Mabion SA (MABP.WA) :
* SIGNS EXPANSION OF PRODUCTION DEAL WITH NOVAVAX
* EXPANSION TAKES PLACE UNDER STATEMENT OF WORKS #8
* STATEMENT OF WORKS #8 INCLUDES CARRYING OUT STABILITY TESTS ON SARS COV-2 RS ACTIVE SUBSTANCE
* ORDER IS LONG-TERM AND WILL BE CARRIED OUT OVER THREE YEAR PERIOD FOR EACH TESTED SERIES
The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: firstname.lastname@example.org